2024 Q3 Form 10-Q Financial Statement

#000149315224032172 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $1.292M $1.181M $674.0K
YoY Change 1074.55% 75.22% 82.16%
Cost Of Revenue $887.0K $667.0K $777.0K
YoY Change 176.32% -14.16% 38.5%
Gross Profit $405.0K $514.0K -$103.0K
YoY Change -291.94% -599.03% -46.07%
Gross Profit Margin 31.35% 43.52% -15.28%
Selling, General & Admin $1.691M $1.470M $1.661M
YoY Change 29.38% -11.5% 21.33%
% of Gross Profit 417.53% 285.99%
Research & Development $1.730M $1.408M $1.355M
YoY Change 27.77% 3.91% 32.71%
% of Gross Profit 427.16% 273.93%
Depreciation & Amortization $28.00K $31.00K $37.00K
YoY Change -40.43% -16.22% -30.19%
% of Gross Profit 6.91% 6.03%
Operating Expenses $3.421M $2.878M $3.016M
YoY Change 28.56% -4.58% 26.19%
Operating Profit -$3.016M -$2.364M -$3.119M
YoY Change 5.01% -24.21% 20.84%
Interest Expense $240.0K
YoY Change -221.21%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$2.876M
YoY Change 3.75%
Income Tax
% Of Pretax Income
Net Earnings -$2.867M -$2.182M -$2.876M
YoY Change 12.79% -24.13% 3.75%
Net Earnings / Revenue -221.9% -184.76% -426.71%
Basic Earnings Per Share -$0.23 -$0.21 -$0.28
Diluted Earnings Per Share -$0.23 -$0.21 -$0.28
COMMON SHARES
Basic Shares Outstanding 12.60M shares 10.45M shares 10.43M shares
Diluted Shares Outstanding 12.26M shares 10.45M shares 10.44M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.06M
YoY Change 30.89%
Cash & Equivalents $20.91M $13.24M $3.319M
Short-Term Investments $18.74M
Other Short-Term Assets $634.0K $657.0K $668.0K
YoY Change 10.65% -1.65% 62.93%
Inventory $328.0K $439.0K $724.0K
Prepaid Expenses
Receivables $912.0K $758.0K $158.0K
Other Receivables $0.00
Total Short-Term Assets $23.10M $15.41M $23.61M
YoY Change 10.72% -34.73% 31.37%
LONG-TERM ASSETS
Property, Plant & Equipment $423.0K $443.0K $513.0K
YoY Change -15.9% -13.65% -28.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $96.00K $96.00K $262.0K
YoY Change -62.2% -63.36% -20.36%
Total Long-Term Assets $3.075M $3.168M $2.804M
YoY Change -16.76% 12.98% -9.4%
TOTAL ASSETS
Total Short-Term Assets $23.10M $15.41M $23.61M
Total Long-Term Assets $3.075M $3.168M $2.804M
Total Assets $26.17M $18.57M $26.41M
YoY Change 6.58% -29.67% 25.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $301.0K $292.0K $774.0K
YoY Change 2.73% -62.27% 150.49%
Accrued Expenses $209.0K $1.208M
YoY Change -86.68% 34.37%
Deferred Revenue $615.0K $611.0K $954.0K
YoY Change -35.26% -35.95% -33.1%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.924M $2.643M $2.983M
YoY Change 2.09% -11.4% 12.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $28.00K
YoY Change -99.03%
Total Long-Term Liabilities $2.335M $2.505M $2.630M
YoY Change -25.47% -4.75% -9.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.924M $2.643M $2.983M
Total Long-Term Liabilities $2.335M $2.505M $2.630M
Total Liabilities $5.259M $5.148M $5.613M
YoY Change -12.31% -8.28% 1.14%
SHAREHOLDERS EQUITY
Retained Earnings -$42.40M -$39.55M -$30.30M
YoY Change 28.88% 30.53% 45.3%
Common Stock $63.33M $52.98M $51.12M
YoY Change 23.15% 3.63% 40.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $20.91M $13.43M $20.80M
YoY Change
Total Liabilities & Shareholders Equity $26.17M $18.57M $26.41M
YoY Change 6.58% -29.67% 25.38%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$2.867M -$2.182M -$2.876M
YoY Change 12.79% -24.13% 3.75%
Depreciation, Depletion And Amortization $28.00K $31.00K $37.00K
YoY Change -40.43% -16.22% -30.19%
Cash From Operating Activities -$2.199M -$2.093M -$2.609M
YoY Change -2.48% -19.78% 20.01%
INVESTING ACTIVITIES
Capital Expenditures $8.000K $8.000K $42.00K
YoY Change -78.38% -80.95% 133.33%
Acquisitions
YoY Change
Other Investing Activities -$3.500M
YoY Change -333.33%
Cash From Investing Activities -$8.000K $7.992M -$3.542M
YoY Change -100.05% -325.64% -339.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $9.850M -$64.00K
YoY Change -12728.21%
NET CHANGE
Cash From Operating Activities -$2.199M -$2.093M -$2.609M
Cash From Investing Activities -$8.000K $7.992M -$3.542M
Cash From Financing Activities $9.850M -$64.00K
Net Change In Cash $7.643M $5.899M -$6.215M
YoY Change -39.49% -194.92% 798.12%
FREE CASH FLOW
Cash From Operating Activities -$2.199M -$2.093M -$2.609M
Capital Expenditures $8.000K $8.000K $42.00K
Free Cash Flow -$2.207M -$2.101M -$2.651M
YoY Change -3.71% -20.75% 20.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2023Q2 ODYS Severance Pay Asset And Liability
SeverancePayAssetAndLiability
usd
CY2023Q2 ODYS Withdrawal Short Term Deposits
WithdrawalShortTermDeposits
usd
ODYS Payments Investment To Short Term Deposits
PaymentsInvestmentToShortTermDeposits
usd
CY2024Q2 ODYS Payments Investment To Short Term Deposits
PaymentsInvestmentToShortTermDeposits
usd
ODYS Proceeds From Issuance Of Shares And Warrants
ProceedsFromIssuanceOfSharesAndWarrants
usd
CY2024Q2 ODYS Proceeds From Issuance Of Shares And Warrants
ProceedsFromIssuanceOfSharesAndWarrants
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39551000 usd
CY2023 ODYS Contract With Customer Liability Additions During Period
ContractWithCustomerLiabilityAdditionsDuringPeriod
usd
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
3000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5344000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
13426000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
463000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-2182000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
13426000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11786000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
685000 usd
ODYS Stock Issued During Period Value Of Shares And Warrants
StockIssuedDuringPeriodValueOfSharesAndWarrants
13887000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5562000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
20796000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
23375000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
337000 usd
CY2023Q2 ODYS Stock Issued During Period Value Of Shares And Warrants
StockIssuedDuringPeriodValueOfSharesAndWarrants
-40000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2876000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
20796000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
20796000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5344000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5562000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-2182000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2876000 usd
us-gaap Depreciation
Depreciation
64000 usd
us-gaap Depreciation
Depreciation
192000 usd
CY2024Q2 us-gaap Depreciation
Depreciation
31000 usd
CY2023Q2 us-gaap Depreciation
Depreciation
37000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
963000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
685000 usd
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
463000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
337000 usd
ODYS Severance Pay Asset And Liability
SeverancePayAssetAndLiability
13000 usd
ODYS Severance Pay Asset And Liability
SeverancePayAssetAndLiability
-54000 usd
CY2024Q2 ODYS Severance Pay Asset And Liability
SeverancePayAssetAndLiability
13000 usd
ODYS Interest And Exchange Differences From Operating Lease Liability
InterestAndExchangeDifferencesFromOperatingLeaseLiability
42000 usd
ODYS Interest And Exchange Differences From Operating Lease Liability
InterestAndExchangeDifferencesFromOperatingLeaseLiability
22000 usd
CY2024Q2 ODYS Interest And Exchange Differences From Operating Lease Liability
InterestAndExchangeDifferencesFromOperatingLeaseLiability
25000 usd
CY2023Q2 ODYS Interest And Exchange Differences From Operating Lease Liability
InterestAndExchangeDifferencesFromOperatingLeaseLiability
13000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-40000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-53000 usd
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-19000 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-49000 usd
ODYS Interest Income In Respect Of Deposits
InterestIncomeInRespectOfDeposits
-96000 usd
ODYS Interest Income In Respect Of Deposits
InterestIncomeInRespectOfDeposits
189000 usd
CY2024Q2 ODYS Interest Income In Respect Of Deposits
InterestIncomeInRespectOfDeposits
-228000 usd
CY2023Q2 ODYS Interest Income In Respect Of Deposits
InterestIncomeInRespectOfDeposits
231000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-614000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
98000 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
635000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
97000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-65000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
94000 usd
CY2024Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-165000 usd
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
31000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-226000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-110000 usd
CY2024Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-112000 usd
CY2023Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-62000 usd
ODYS Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
227000 usd
ODYS Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
94000 usd
CY2024Q2 ODYS Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
118000 usd
CY2023Q2 ODYS Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
50000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
225000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
387000 usd
CY2024Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
95000 usd
CY2023Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
104000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
477000 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-107000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
409000 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-1000 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
11000 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-3000 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-39000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-120000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-119000 usd
CY2024Q2 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-60000 usd
CY2023Q2 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-59000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-127000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-683000 usd
CY2024Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-52000 usd
CY2023Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-455000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
419000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
89000 usd
CY2024Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
66000 usd
CY2023Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
152000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
40000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
310000 usd
CY2024Q2 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-25000 usd
CY2023Q2 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
128000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3323000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5083000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2093000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2609000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
57000 usd
CY2024Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8000 usd
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42000 usd
ODYS Withdrawal Short Term Deposits
WithdrawalShortTermDeposits
8000000 usd
ODYS Withdrawal Short Term Deposits
WithdrawalShortTermDeposits
3000000 usd
CY2024Q2 ODYS Withdrawal Short Term Deposits
WithdrawalShortTermDeposits
8000000 usd
ODYS Payments Investment To Short Term Deposits
PaymentsInvestmentToShortTermDeposits
18500000 usd
CY2023Q2 ODYS Payments Investment To Short Term Deposits
PaymentsInvestmentToShortTermDeposits
3500000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7970000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15557000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7992000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3542000 usd
ODYS Proceeds From Issuance Of Shares And Warrants
ProceedsFromIssuanceOfSharesAndWarrants
13913000 usd
CY2023Q2 ODYS Proceeds From Issuance Of Shares And Warrants
ProceedsFromIssuanceOfSharesAndWarrants
-64000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13913000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-64000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
4647000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6727000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
5899000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6215000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8945000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10099000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7672000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9583000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-40000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-53000 usd
CY2024Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-19000 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-49000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13552000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3319000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13552000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3319000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
120000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
465000 usd
CY2024Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
33000 usd
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
382000 usd
ODYS Termination Of Rightofuse Assets In Exchange For Cancellation Of Operating Lease Obligations
TerminationOfRightofuseAssetsInExchangeForCancellationOfOperatingLeaseObligations
-55000 usd
ODYS Termination Of Rightofuse Assets In Exchange For Cancellation Of Operating Lease Obligations
TerminationOfRightofuseAssetsInExchangeForCancellationOfOperatingLeaseObligations
-25000 usd
CY2024Q2 ODYS Termination Of Rightofuse Assets In Exchange For Cancellation Of Operating Lease Obligations
TerminationOfRightofuseAssetsInExchangeForCancellationOfOperatingLeaseObligations
-24000 usd
CY2023Q2 ODYS Termination Of Rightofuse Assets In Exchange For Cancellation Of Operating Lease Obligations
TerminationOfRightofuseAssetsInExchangeForCancellationOfOperatingLeaseObligations
-25000 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_804_eus-gaap--NatureOfOperations_zfjCCWHxKT45" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_82F_zqDcVOTiU5Nd">GENERAL</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 49.6pt; text-align: justify; text-indent: -49.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a</b>.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Odysight.ai Inc (the “Company”), formerly known as ScoutCam Inc., was incorporated under the laws of the State of Nevada on March 22, 2013.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s wholly owned subsidiary, Odysight.ai Ltd (“Odysight.ai”), formerly known as ScoutCam Ltd., was incorporated in the State of Israel on January 3, 2019, and was merged into the Company on December 31, 2019, in a share exchange transaction, following which the surviving operations of the merged entity were the operations of Odysight.ai. On February 28, 2024, D. VIEW Ltd., a wholly owned subsidiary of the Company, was incorporated in the state of the Israel to act as a local representative for the defense market in Israel.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, through its subsidiaries, is pioneering solutions for the Predictive Maintenance (PdM) and Condition Based Monitoring (CBM) markets with its visualization and AI platform. The Company’s video sensor-based platform provides solutions for critical systems in the aviation, transportation, and energy industries. Its video-based sensors, embedded software, and AI algorithms are deployed in hard-to-reach locations and harsh environments across a variety of PdM and CBM use cases and allow maintenance and operations teams visibility into areas which are inaccessible under normal operation, or where the operating ambience is not suitable for continuous real-time monitoring. Some of the Company’s products utilize micro visualization technology in medical devices for minimally invasive medical procedures.</span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ODYSIGHT.AI INC. (Formerly known as ScoutCam Inc.)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – GENERAL </b>(continued):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 60.65pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b</b>.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since the incorporation of Odysight.ai and through June 30, 2024, the Company accumulated a deficit of approximately $<span id="xdx_904_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3n3_dixL_c20240630_z0feP8AVxgKk" title="Accumulated deficit::XDX::39551"><span style="-sec-ix-hidden: xdx2ixbrl0592">39.5</span></span> million and its activities have been funded mainly by its shareholders. The Company’s management believes the Company’ cash and cash resources as of June 30, 2024, as well as its proceeds from issuance of common stock in the private offering as detailed in Note 10, will allow the Company to fund its operating plan through at least the next 12 months from the filing date of these Consolidated Financial Statements. However, the Company expects to continue to incur significant research and development and other costs related to its ongoing operations, requiring the Company to obtain additional funding in order to continue its future operations until becoming profitable.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_zTwms4CkvzU7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c. <span id="xdx_867_zCoUCAPt37d8">Use of estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, deferred taxes, inventory impairment and stock-based compensation, as well as in estimates used in applying the revenue recognition policy. Actual results may differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ODYSIGHT.AI INC. (Formerly known as ScoutCam Inc.)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES </b>(continued):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Operating Lease Payments
OperatingLeasePayments
297000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
119000 usd
CY2024Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
146000 usd
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
59000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y10M9D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06 pure
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
281000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
526000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
423000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
151000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1381000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
258000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1123000 usd
CY2024Q2 us-gaap Share Price
SharePrice
5.55
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
4.50
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.0139 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0423 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
435000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2455069 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.46
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
91000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.5
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
23335 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2522734 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.5
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1341218 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
3.49
us-gaap Share Based Compensation
ShareBasedCompensation
963000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
685000 usd
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
463000 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
337000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1368000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
977000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1181000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
674000 usd
CY2024Q2 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P7Y
CY2024Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1136000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1256000 usd
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2195000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2322000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1256000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1495000 usd
ODYS Contract With Customer Asset Contract Costs
ContractWithCustomerAssetContractCosts
-120000 usd
CY2023 ODYS Contract With Customer Asset Contract Costs
ContractWithCustomerAssetContractCosts
-239000 usd
CY2024Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1136000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1256000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2322000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3644000 usd
ODYS Contract With Customer Liability Additions During Period
ContractWithCustomerLiabilityAdditionsDuringPeriod
161000 usd
ODYS Contract With Customer Liability Revenue Recognized Development Services
ContractWithCustomerLiabilityRevenueRecognizedDevelopmentServices
-288000 usd
CY2023 ODYS Contract With Customer Liability Revenue Recognized Development Services
ContractWithCustomerLiabilityRevenueRecognizedDevelopmentServices
-1322000 usd
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2195000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2322000 usd
CY2024Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2200000 usd
CY2024Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
252000 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
445000 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
184000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
34000 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
25000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
439000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
504000 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
29000 usd
ODYS Royalties Agreement Description
RoyaltiesAgreementDescription
Pursuant to the agreement with an IIA relating to the program, the Company is required to pay royalties of 3% to the IIA up to the amount of IIA funding received and the accrued interest repayment of the grant is contingent upon the Company successfully completing its enhancement plans and generating sales from the enhancements preformed.

Files In Submission

Name View Source Status
0001493152-24-032172-index-headers.html Edgar Link pending
0001493152-24-032172-index.html Edgar Link pending
0001493152-24-032172.txt Edgar Link pending
0001493152-24-032172-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
odys-20240630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
odys-20240630_def.xml Edgar Link unprocessable
odys-20240630_lab.xml Edgar Link unprocessable
odys-20240630_pre.xml Edgar Link unprocessable
odys-20240630_cal.xml Edgar Link unprocessable